Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate Monohydrate-Reference-Cited by-同舟云学术

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin Phosphate Monohydrate

Published:2022-01 Issue:1 Volume:111 Page:2-13
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Charoo Naseem A.^ORCID,Abdallah Daud B.,Bakheit Ahmed Abdalla,Haque Kashif Ul,Hassan Hassan Ali,Abrahamsson Bertil,Cristofoletti Rodrigo,Langguth Peter,Mehta Mehul,Parr Alan^ORCID,Polli James E.^ORCID,Shah Vinod P.,Tajiri Tomokazu^ORCID,Dressman Jennifer

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference86 articles.

1. Diabtes, key facts, 13th April;WHO,2021

2. Januvia® 100 mg Film-Coated Tablets,2018

3. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System,2017

4. Guideline on the Investigation of Bioequivalence. Doc.Ref.:CPMP/EWP/QWP/1401/98 Rev. 1/Corr,2010

5. Biopharmaceutics Classification System-Based Biowaivers,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biowaiver based on biopharmaceutics classification system: Considerations and requirements;Pharmaceutical Science Advances;2024-12

2. Comparative in-Vitro dissolution study of some sitagliptin generic tablets under biowaiver conditions by UV-Spectroscopy;Current Trends in Pharmacy and Pharmaceutical Chemistry;2024-09-15

3. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Isavuconazonium Sulfate;Journal of Pharmaceutical Sciences;2024-02

4. Pharmacokinetics and relative bioavailability of sitagliptin hydrochloride and sitagliptin phosphate tablets formulations: a randomized, open-label, crossover study in healthy male volunteers;Generics and Biosimilars Initiative Journal;2023-04-15

5. Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies;Pharmaceutics;2023-04-14